LYCLEAR

This brand name is authorized in Australia, Ireland, Israel, Malta, United Kingdom

Active ingredients

The drug LYCLEAR contains one active pharmaceutical ingredient (API):

1 Permethrin UNII 509F88P9SZ - PERMETHRIN

The principal physiological action in insects (lice) exposed to permethrin is induction of electrochemical abnormalities across the membranes of excitable cells, leading to sensory hyperexcitability, inco-ordination and prostration. It is assumed that the mode of action against arachnids (mites) is similar. Read about Permethrin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LYCLEAR Cream	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
LYCLEAR Creme rinse	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
P03AC04	Permethrin	P Antiparasitic products, insecticides and repellents → P03 Ectoparasiticides, incl. scabicides, insecticides and repellents → P03A Ectoparasiticides, incl. scabicides → P03AC Pyrethrines, incl. synthetic compounds
Discover more medicines within P03AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 3054R
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 33880, 33965
Country: IE	Health Products Regulatory Authority	Identifier(s): 32292
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2987
Country: MT	Medicines Authority	Identifier(s): AA565/22402